With full genetic control and visibility into neural activity and behavior, MIT scientists map out chemical’s role in behavior.

An overreliance on medication as the first-line treatment for depression can lead some people to be labeled with treatment-resistant depression when there are other viable alternatives for relief.

Patients who undergo transcranial magnetic stimulation say it’s painless, with few to no side effects. The treatment isn’t yet widely accessible, but for those who use it, the effects can be profound.

Existing genetic data and sequencing tools are overwhelmingly based on people of European ancestry, which excludes much of the rich genetic variation of the world.

Pinpointing the molecular targets behind the subjective effects of psychedelic drugs could help clinicians and researchers better treat psychiatric conditions.

While the brain acquires resistance to continuous treatment with mGluR5 inhibitor drugs, lasting effects may still arise if dosing occurs intermittently and during a developmental-critical period.

Novel method, developed by McGovern Institute researchers, may lead to safer, more efficient gene therapies.

Combat veteran and PhD candidate Omar Rutledge drives research on post-traumatic stress disorder.

The pandemic has put a spotlight on a once little-discussed disorder – hoarding. But hoarding disorder is not what you might think.